Forum Topic News
  • Conversation: EU approves AZ’ Bydureon BCise device

    • August 30, 2018 4:34 PM BST
      • Post(s)

      EU approves AZ’ Bydureon BCise device

      AstraZeneca says the European Commission has approved a new formulation of its once-weekly diabetes drug Bydureon.
      According to the firm, Bydureon BCise (exenatide extended release) is an improved single-dose, pre-filled pen device that requires no titration.
      It is approved for use in combination with other glucose-lowering medicines, including basal insulin, to help improve glycaemic control in adults with type-2 diabetes whose blood sugar levels are inadequately controlled by other glucose-lowering medicines together with diet and exercise.
      Read more:

Add Reputation

Do you want to add reputation for this member by this post?

or cancel